Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics EBITDA Margin 2010-2025 | NKTR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Nektar Therapeutics (NKTR) over the last 10 years. The current EBITDA margin for Nektar Therapeutics as of March 31, 2025 is .
  
Nektar Therapeutics EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.09B $-0.11B -126.74%
2024-12-31 $0.10B $-0.10B -103.06%
2024-09-30 $0.09B $-0.14B -153.76%
2024-06-30 $0.09B $-0.16B -166.67%
2024-03-31 $0.09B $-0.16B -174.44%
2023-12-31 $0.09B $-0.18B -198.89%
2023-09-30 $0.09B $-0.21B -236.36%
2023-06-30 $0.09B $-0.21B -243.18%
2023-03-31 $0.09B $-0.31B -345.56%
2022-12-31 $0.09B $-0.36B -391.40%
2022-09-30 $0.10B $-0.43B -447.92%
2022-06-30 $0.10B $-0.49B -500.00%
2022-03-31 $0.10B $-0.44B -427.18%
2021-12-31 $0.10B $-0.43B -423.53%
2021-09-30 $0.10B $-0.43B -426.00%
2021-06-30 $0.11B $-0.42B -396.19%
2021-03-31 $0.13B $-0.39B -305.56%
2020-12-31 $0.15B $-0.41B -268.63%
2020-09-30 $0.16B $-0.42B -255.49%
2020-06-30 $0.16B $-0.41B -251.53%
2020-03-31 $0.14B $-0.45B -328.47%
2019-12-31 $0.11B $-0.44B -384.21%
2019-09-30 $0.12B $-0.42B -348.33%
2019-06-30 $0.12B $-0.43B -357.14%
2019-03-31 $1.18B $0.67B 56.17%
2018-12-31 $1.19B $0.70B 58.54%
2018-09-30 $1.25B $0.78B 62.05%
2018-06-30 $1.37B $0.94B 68.70%
2018-03-31 $0.32B $-0.08B -24.30%
2017-12-31 $0.31B $-0.04B -14.29%
2017-09-30 $0.25B $-0.05B -20.40%
2017-06-30 $0.13B $-0.15B -115.04%
2017-03-31 $0.13B $-0.14B -107.63%
2016-12-31 $0.17B $-0.10B -58.79%
2016-09-30 $0.17B $-0.10B -56.89%
2016-06-30 $0.19B $-0.06B -32.46%
2016-03-31 $0.18B $-0.07B -38.12%
2015-12-31 $0.23B $-0.02B -7.36%
2015-09-30 $0.21B $-0.03B -11.79%
2015-06-30 $0.29B $0.06B 19.30%
2015-03-31 $0.29B $0.08B 26.12%
2014-12-31 $0.20B $0.00B -1.49%
2014-09-30 $0.21B $0.00B -0.94%
2014-06-30 $0.14B $-0.09B -63.12%
2014-03-31 $0.15B $-0.10B -67.12%
2013-12-31 $0.15B $-0.11B -71.14%
2013-09-30 $0.14B $-0.11B -81.29%
2013-06-30 $0.10B $-0.14B -144.79%
2013-03-31 $0.09B $-0.13B -155.81%
2012-12-31 $0.08B $-0.13B -156.79%
2012-09-30 $0.08B $-0.12B -155.26%
2012-06-30 $0.09B $-0.11B -125.88%
2012-03-31 $0.08B $-0.11B -144.87%
2011-12-31 $0.07B $-0.11B -153.52%
2011-09-30 $0.10B $-0.09B -94.00%
2011-06-30 $0.11B $-0.08B -70.27%
2011-03-31 $0.14B $-0.04B -30.66%
2010-12-31 $0.16B $-0.01B -6.92%
2010-09-30 $0.15B $0.00B 1.96%
2010-06-30 $0.13B $-0.02B -16.00%
2010-03-31 $0.10B $-0.05B -55.79%
2009-12-31 $0.07B $-0.08B -112.50%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.307B $0.098B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.499B 30.20
Zoetis (ZTS) United States $70.868B 26.44
Takeda Pharmaceutical (TAK) Japan $48.811B 9.71
Daiichi Sankyo, - (DSNKY) Japan $42.149B 21.60
BeOne Medicines - (ONC) Cayman Islands $26.906B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.786B 0.00
Summit Therapeutics (SMMT) United States $18.232B 0.00
Merck (MKKGY) Germany $16.850B 12.35
Shionogi (SGIOY) Japan $14.717B 14.74
United Therapeutics (UTHR) United States $13.283B 11.75
Neurocrine Biosciences (NBIX) United States $12.777B 43.77
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Corcept Therapeutics (CORT) United States $7.664B 62.30
Stevanato Group S.p.A (STVN) Italy $7.447B 45.54
Ionis Pharmaceuticals (IONS) United States $6.844B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.636B 0.00
Grifols, S.A (GRFS) Spain $6.243B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.367B 0.00
Hypermarcas (HYPMY) Brazil $3.183B 20.94
Crinetics Pharmaceuticals (CRNX) United States $2.790B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.639B 14.27
Catalyst Pharmaceuticals (CPRX) United States $2.618B 9.17
NewAmsterdam Pharma (NAMS) Netherlands $2.229B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.879B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.871B 0.00
ARS Pharmaceuticals (SPRY) United States $1.622B 0.00
Endo (NDOI) United States $1.603B 0.00
Ocular Therapeutix (OCUL) United States $1.532B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Guardian Pharmacy Services (GRDN) United States $1.320B 0.00
Harrow (HROW) United States $1.165B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.025B 20.51
Ardelyx (ARDX) United States $1.022B 0.00
Enliven Therapeutics (ELVN) United States $1.017B 0.00
Verve Therapeutics (VERV) United States $1.006B 0.00
Dyne Therapeutics (DYN) United States $0.996B 0.00
Collegium Pharmaceutical (COLL) United States $0.975B 5.26
Akebia Therapeutics (AKBA) United States $0.951B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.864B 0.00
Cronos Group (CRON) Canada $0.787B 0.00
Xeris Biopharma Holdings (XERS) United States $0.743B 0.00
Elite Pharmaceuticals (ELTP) United States $0.640B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
USANA Health Sciences (USNA) United States $0.610B 13.27
Xencor (XNCR) United States $0.599B 0.00
KalVista Pharmaceuticals (KALV) United States $0.596B 0.00
Bioventus (BVS) United States $0.577B 14.62
Amylyx Pharmaceuticals (AMLX) United States $0.562B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
Organogenesis (ORGO) United States $0.539B 0.00
Zevra Therapeutics (ZVRA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.478B 9.99
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Tourmaline Bio (TRML) United States $0.422B 0.00
AleAnna (ANNA) United States $0.420B 0.00
Altimmune (ALT) United States $0.386B 0.00
Savara (SVRA) United States $0.379B 0.00
Aquestive Therapeutics (AQST) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Heron Therapeutics (HRTX) United States $0.336B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 26.42
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.258B 0.00
OmniAb (OABI) United States $0.236B 0.00
Liminatus Pharma (LIMN) United States $0.235B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
China SXT Pharmaceuticals (SXTC) China $0.218B 0.00
MediWound (MDWD) Israel $0.209B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.196B 0.00
ProKidney (PROK) United States $0.187B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.143B 0.00
Avita Medical (RCEL) United States $0.143B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Galectin Therapeutics (GALT) United States $0.138B 0.00
Cardiol Therapeutics (CRDL) Canada $0.127B 0.00
Korro Bio (KRRO) United States $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.112B 0.00
Nutriband (NTRB) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.106B 17.45
VAXART, INC (VXRT) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.094B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Achieve Life Sciences (ACHV) Canada $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.065B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 35.00
ElectroCore (ECOR) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
FibroGen (FGEN) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.01
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00
SciSparc (SPRC) Israel $0.000B 0.00